Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Glucuronidation of active tamoxifen metabolites by the human UDP glucuronosyltransferases.

Glucuronidation of active tamoxifen metabolites by the human UDP glucuronosyltransferases. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Glucuronidation of active tamoxifen metabolites by the human UDP glucuronosyltransferases. Abstract Text:

    dongxiao sunDongxiao Sun,arun k sharmaArun K Sharma,ryan w dellingerRyan W Dellinger,andrea s blevins-primeauAndrea S Blevins-Primeau,renee m ballietRenee M Balliet,gang chenGang Chen,telih boyiriTelih Boyiri,shantu aminShantu Amin,philip lazarusPhilip Lazarus,dongxiao sunDongxiao Sun,arun k sharmaArun K Sharma,ryan w dellingerRyan W Dellinger,andrea s blevins-primeauAndrea S Blevins-Primeau,renee m ballietRenee M Balliet,gang chenGang Chen,telih boyiriTelih Boyiri,shantu aminShantu Amin,philip lazarusPhilip Lazarus,

    Tamoxifen (TAM) is an antiestrogen that has been widely used in the treatment and prevention of breast cancer in women. One of the major mechanisms of metabolism and elimination of TAM and its major active metabolites 4-hydroxytamoxifen (4-OH-TAM) and 4-OH-N-desmethyl-TAM (endoxifen; 4-hydroxy-N-desmethyl-tamoxifen) is via glucuronidation. Although limited studies have been performed characterizing the glucuronidation of 4-OH-TAM, no studies have been performed on endoxifen. In the present study, characterization of the glucuronidating activities of human UDP glucuronosyltransferases (UGTs) against isomers of 4-OH-TAM and endoxifen was performed. Using homogenates of individual UGT-overexpressing cell lines, UGTs 2B7 approximately 1A8 > UGT1A10 exhibited the highest overall O-glucuronidating activity against trans-4-OH-TAM as determined by Vmax/K(M), with the hepatic enzyme UGT2B7 exhibiting the highest binding affinity and lowest K(M) (3.7 microM). As determined by Vmax/K(M), UGT1A10 exhibited the highest overall O-glucuronidating activity against cis-4-OH-TAM, 10-fold higher than the next-most active UGTs 1A1 and 2B7, but with UGT1A7 exhibiting the lowest K(M). Although both N- and O-glucuronidation occurred for 4-OH-TAM in human liver microsomes, only O-glucuronidating activity was observed for endoxifen; no endoxifen-N-glucuronidation was observed for any UGT tested. UGTs 1A10 approximately 1A8 > UGT2B7 exhibited the highest overall glucuronidating activities as determined by Vmax/K(M) for trans-endoxifen, with the extrahepatic enzyme UGT1A10 exhibiting the highest binding affinity and lowest K(M) (39.9 microM). Similar to that observed for cis-4-OH-TAM, UGT1A10 also exhibited the highest activity for cis-endoxifen. These data suggest that several UGTs, including UGTs 1A10, 2B7, and 1A8 play an important role in the metabolism of 4-OH-TAM and endoxifen.

    Glucuronidation of active tamoxifen metabolites by the human UDP glucuronosyltransferases. Publishing Authors By Initials

    d sunD Sun,ak sharmaAK Sharma,rw dellingerRW Dellinger,as blevins-primeauAS Blevins-Primeau,rm ballietRM Balliet,g chenG Chen,t boyiriT Boyiri,s aminS Amin,p lazarusP Lazarus,d sunD Sun,ak sharmaAK Sharma,rw dellingerRW Dellinger,as blevins-primeauAS Blevins-Primeau,rm ballietRM Balliet,g chenG Chen,t boyiriT Boyiri,s aminS Amin,p lazarusP Lazarus,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Glucuronidation of active tamoxifen metabolites by the human UDP glucuronosyltransferases. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Drug metabolism and disposition: the biological fa

    VOLUME: 35

    Page Numbers: 2006-14

    Journal Abbreviation: Drug Metab. Dispos.

    ISSN: 0090-9556

    DAY: 30

    MONTH: 07

    YEAR: 2007

    Glucuronidation of active tamoxifen metabolites by the human UDP glucuronosyltransferases. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9421550

    Glucuronidation of active tamoxifen metabolites by the human UDP glucuronosyltransferases. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Glucuronidation of active tamoxifen metabolites by the human UDP glucuronosyltransferases. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Glucuronidation of active tamoxifen metabolites by the human UDP glucuronosyltransferases.

    AFFILIATION: Cancer Prevention and Control, Penn State Cancer Institute, Department of Pharmacology, Penn State University College of Medicine, Hershey, PA 17033, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States PHS

    GRANT: P01-68384

    ACRONYM:

    MEDLINETA: Drug Metab Dispos

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Glucuronidation of active tamoxifen metabolites by the human UDP glucuronosyltransferases Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News